Impact of Age on Survival of Patients with Operable Breast Cancer
محل انتشار: فصلنامه سرطان پستان، دوره: 2، شماره: 4
سال انتشار: 1394
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 165
فایل این مقاله در 5 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
این مقاله در بخشهای موضوعی زیر دسته بندی شده است:
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_ARCHB-2-4_005
تاریخ نمایه سازی: 24 خرداد 1400
چکیده مقاله:
Background: Breast cancer arising in young patients (≤ ۴۰ years) is beingconsidered as a distinct clinical entity with more aggressive tumor features andpoorer survival. Our aim was to assess the impact of age on survival among a largegroup of Iranian women diagnosed with breast cancer.Methods: In a cross-sectional study, demographic and clinicopathologicalcharacteristics of patients with breast cancer who were treated in two referralcenters in Tehran, Iran during the past ۱۳ years were reviewed and extracted froman electronic database. Patients were divided into two groups based on the age atthe time of diagnosis (≤۴۰ and >۴۰ years). The association of age with differentclinicopathological features and its impact on disease-free survival were assessed.Results: Study population comprised of ۳۵۳(۲۶.۱%) patients who were ۴۰years old or younger and ۱۰۰۰(۷۳.۹%) who were older. Compared to olderpatients, younger participants had more commonly tumor size larger than ۵ cm (P=۰.۰۳۴), higher chance of lymph node metastasis (P= ۰.۰۳۶), and overexpression ofHER-۲ (P = ۰.۰۰۴). No significant differences were observed between the twogroups regarding ER, PR, and LNR (lymph node ratio). Age was the only factoraffecting patients' disease-free survival and younger patients had higher chance oflocal or distant metastases compared to older subjects (HR: ۱.۴۹, ۹۵%CI: ۱.۰۲-۲.۱۷, P= ۰.۰۳۸).Conclusions: Based on the results of current study, it can be suggested thatyounger patients who are diagnosed with breast cancer tend to have larger tumorsize, higher chance of lymph node metastasis and overexpression of HER-۲compared to patients older than ۴۰ years. Age was the only significant factor thatwas associated with shorter disease-free survival.
کلیدواژه ها:
نویسندگان
Mohamadreza Neishaboury
Kaviani Breast Disease Institute (KBDI), Tehran, Iran- Department of Surgery, Tehran University of Medical Sciences, Tehran, Iran
Armita Aboutorabi
Kaviani Breast Disease Institute (KBDI), Tehran, Iran
Behnam Behboudi
Department of Surgery, Tehran University of Medical Sciences, Tehran, Iran
Babak Mirminachi
Department of Surgery, Tehran University of Medical Sciences, Tehran, Iran
Kahtereh Jamei
Kaviani Breast Disease Institute (KBDI), Tehran, Iran
Marzieh Kord Zanganeh
Kaviani Breast Disease Institute (KBDI), Tehran, Iran- Department of Surgery, Tehran University of Medical Sciences, Tehran, Iran